Preparative use of isolated CYP102 monooxygenases-A critical appraisal

Journal of Biotechnology

Volumn 124, Issue 4, 2006, Pages 662-669

  Eiben, Sabine ^a   Kaysser, Leonard ^a   Maurer, Steffen ^a   Kühnel, Katja ^a   Urlacher, Vlada B ^a   Schmid, Rolf D ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Co factor regeneration; Enzyme stability; Enzyme technology; P450 monooxygenase

Indexed keywords

BACTERIA; BIOCHEMISTRY; CHARGE TRANSFER; CHEMICAL BONDS; ELECTRONS; SUBSTRATES;

CO-FACTOR REGENERATION; ENZYME STABILITY; ENZYME TECHNOLOGY; P450 MONOOXYGENASE;

ENZYMES;

CYTOCHROME P450; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNSPECIFIC MONOOXYGENASE;

BIOCATALYST; BIOTECHNOLOGY; CATALYST; ELECTRON TRANSPORT; ENZYME SPECIFICITY; NONHUMAN; ORGANIC CHEMISTRY; PRIORITY JOURNAL; REVIEW; SOLUBILITY; THERMOSTABILITY;

BACTERIAL PROTEINS; CATALYSIS; COENZYMES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME STABILITY; INDUSTRIAL MICROBIOLOGY; MIXED FUNCTION OXYGENASES; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

BACTERIA (MICROORGANISMS);

EID: 33746021124     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2006.02.013     Document Type: Review

References (43)

1. Appel D., Lutz-Wahl S., Fischer P., Schwaneberg U., and Schmid R.D. A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes. J. Biotechnol. 88 (2001) 167-171
2. Boddupalli S.S., Estabrook R.W., and Peterson J.A. Fatty acid monooxygenation by cytochrome P-450BM-3. J. Biol. Chem. 265 (1990) 4233-4239
3. Cirino P.C., and Arnold F.H. A self-sufficient peroxide-driven hydroxylation biocatalyst. Angew. Chem. Int. Ed. Engl. 42 (2003) 3299-3301
4. Carmichael A.B., and Wong L.L. Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons. Eur. J. Biochem. 268 (2001) 3117-3125
5. Dohr O., Paine M.J.I., Friedberg T., Roberts G.C.K., and Wolf C.R. Engineering of a functional human NADH-dependent cytochrome P450 system. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 81-86
6. Elmore C.L., and Porter T.D. Modification of the nucleotide cofactor-binding site of cytochrome P-450 reductase to enhance turnover with NADH in vivo. J. Biol. Chem. 277 (2002) 48960-48964
7. Glieder A., Farinas E.T., and Arnold F.H. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nat. Biotechnol. 20 (2002) 1135-1139
8. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
9. Gustafsson M.C.U., Roitel O., Marshall K.R., Noble M.A., Chapman S.K., Pessegueiro A., Fulco A.J., Cheesman M.R., von Wachenfeldt C., and Munro A.W. Expression, purification, and characterization of Bacillus subtilis cytochromes P450CYP102A2 and CYP102A3: Flavocytochronie homologues of P450BM3 from Bacillus megaterium. Biochemistry 43 (2004) 5474-5487
10. Gutierrez A., Doehr O., Paine M., Wolf C.R., Scrutton N.S., and Roberts G.C. Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: properties of the soluble W676H and W676A mutant reductases. Biochemistry 39 (2000) 15990-15999
11. Haines D.C., Tomchick D.R., Machius M., and Peterson J.A. Pivotal role of water in the mechanism of P450BM-3. Biochemistry 40 (2001) 13456-13465
12. + specificity-reversal mutant. Biochemistry 35 (1996) 5670-5678
13. Ladner, W., Staudenmaier, H.R., Hauer, B., Müller, U., Pressler, U., Meyer, J., Siegel, H., 1995. In US Patent BASF Aktiengesellschaft.
14. Lentz O., Feenstra A., Habicher T., Hauer B., Schmid R.D., and Urlacher V.B. Altering the regioselectivity of cytochrome P450 CYP102A3 of Bacillus subtilis by using a new versatile assay system. Chembiochem 7 (2006) 345-350
15. Lentz O., Urlacher V., and Schmid R.D. Substrate specificity of native and mutated cytochrome P450 (CYP102A3) from Bacillus subtilis. J. Biotechnol. 108 (2004) 41-49
16. Li H., and Poulos T.L. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat. Struct. Biol. 4 (1997) 140-146
17. Li H.Y., Darwish K., and Poulos T.L. Characterization of recombinant Bacillus megaterium cytochrome P-450 BM-3 and its 2 functional domains. J. Biol. Chem. 266 (1991) 11909-11914
18. Li Q.S., Ogawa J., Schmid R.D., and Shimizu S. Engineering cytochrome P450 BM-3 for oxidation of polycyclic aromatic hydrocarbons. Appl. Environ. Microbiol. 67 (2001) 5735-5739
19. Li Q.S., Ogawa J., Schmid R.D., and Shimizu S. Residue size at position 87 of cytochrome P450 BM-3 determines its stereoselectivity in propylbenzene and 3-chlorostyrene oxidation. FEBS. Lett. 508 (2001) 249-252
20. Li Q.-S., Schwaneberg U., Fischer P., and Schmid R.D. Directed evolution of the fatty-acid hydroxylase P450 BM-3 into an indole-hydroxylating catalyst. Chem. Eur. J. 6 (2000) 1481-1486
21. Marohnic C.C., Bewley M.C., and Barber M.J. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase. Biochemistry 42 (2003) 11170-11182
22. Maurer S., Kühnel K., Kaysser L.O., Eiben S., Schmid R.D., and Urlacher V.B. Catalytic hydroxylation in biphasic systems using CYP102A1 (P450 BM-3) mutants. Adv. Synth. Catal. 7-8 (2005) 1090-1098
23. + cofactor recycling system: towards a technical application of heme-containing monooxygenases in fine chemical synthesis. Adv. Synth. Catal. 345 (2003) 802-810
24. Meinhold P., Peters M.W., Chen M.M., Takahashi K., and Arnold F.H. Direct conversion of ethane to ethanol by engineered cytochrome P450 BM3. Chembiochem 6 (2005) 1765-1768
25. Munro A.W., Lindsay J.G., Coggins J.R., Kelly S.M., and Price N.C. Analysis of the structural stability of the multidomain enzyme flavocytochrome P-450 BM3. Biochim. Biophys. Acta 1296 (1996) 127-137
26. Narhi L.O., and Fulco A.J. Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J. Biol. Chem. 261 (1986) 7160-7169
27. Panke S., Witholt B., Schmid A., and Wubbolts M.G. Towards a biocatalyst for (S)-styrene oxide production: characterization of the styrene degradation pathway of Pseudomonas sp. strain VLB120. Appl. Environ. Microbiol. 64 (1998) 2032-2043
28. Peitsch M.C. Protein modeling by e-mail. Bio-Technology 13 (1995) 658-660
29. Peters M.W., Meinhold P., Glieder A., and Arnold F.H. Regio-and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. J. Am. Chem. Soc. 125 (2003) 13442-13450
30. Petzoldt, K., Annen, K., Laurent, H., Wiechert, R., 1982. In US Patent Schering Aktiengesellschaft (Berlin, Germany).
31. Picataggio S., Rohrer T., Deanda K., Lanning D., Reynolds R., Mielenz J., and Eirich L.D. Metabolic engineering of Candida tropicalis for the production of long-chain dicarboxylic acids. Biotechnology (N.Y.) 10 (1992) 894-898
32. Ravichandran K.G., Boddupalli S.S., Hasermann C.A., Peterson J.A., and Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science 261 (1993) 731-736
33. Salazar O., Cirino P.C., and Arnold F.H. Thermostabilization of a cytochrome p450 peroxygenase. Chembiochem 4 (2003) 891-893
34. Schmid A., Dordick J.S., Hauer B., Kiener A., Wubbolts M., and Witholt B. Industrial biocatalysis today and tomorrow. Nature 409 (2001) 258-268
35. Schneider S., Wubbolts M.G., Oesterhelt G., Sanglard D., and Witholt B. Controlled regioselectivity of fatty acid oxidation by whole cells producing cytochrome P450BM-3 monooxygenase under varied dissolved oxygen concentrations. Biotechnol. Bioeng. 64 (1999) 333-341
36. Schwede T., Kopp J., Guex N., and Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31 (2003) 3381-3385
37. Serizawa N., and Matsuoka T. A 2 component-type cytochrome-P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of Ml-236b to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-a reductase. Biochim. Biophys. Acta 1084 (1991) 35-40
38. Sevrioukova I.F., Li H., Zhang H., Peterson J.A., and Poulos T.L. Structure of a cytochrome P450-redox partner electron-transfer complex. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1863-1868
39. Sippl M.J. Recognition of errors in three-dimensional structures of proteins. Proteins 17 (1993) 355-362
40. Udit A.K., and Gray H.B. Electrochemistry of heme-thiolate proteins. Biochem. Biophys. Res. Commun. 338 (2005) 470-476
41. Urlacher V.B., Makhsumkhanov A., and Schmid R.D. Biotransformation of beta-ionone by engineered cytochrome P450 BM-3. Appl. Microbiol. Biotechnol. (2005) 1-7
42. Wang M., Roberts D.L., Paschke R., Shea T.M., Masters B.S., and Kim J.J. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN-and FAD-containing enzymes. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8411-8416
43. Warman A.J., Roitel O., Neeli R., Girvan H.M., Seward H.E., Murray S.A., McLean K.J., Joyce M.G., Toogood H., Holt R.A., Leys D., Scrutton N.S., and Munro A.W. Flavocytochrome P450BM3: an update on structure and mechanism of a biotechnologically important enzyme. Biochem. Soc. Trans. 33 (2005) 747-753